Geri-dryl Allergy Relief
FDA Label NDC 67296-1758

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Redpharm Drug, Inc. for the product Geri-dryl Allergy Relief (NDC 67296-1758). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Diphenhydramine Hydrochloride 25mg

Purpose

Antihistamine

Directions

  • do not exceed recommended dose
  • adults and children 12 years and over, take 1 to 2 tablets every 4-6 hours, as needed; not more than 12 tablets in 24 hours, or as directed by a doctor
  • children under 12 years: consult a doctor

Other Information

  • each tablet contains: calcium 25mg
  • store at room temperature 15⁰C - 30⁰C (59⁰F - 86⁰F)
  • for institutional use only

Package Label

New! Ultra Small Tablets
NDC 57896-681-01

GERICARE
GERI-DRYL
(ALLERGY RELIEF)
Diphenhydramine HCl
Antihistamine
Compare to active ingredient in Benadryl Ultratabs
PACKAGE NOT CHILD RESISTANT
100 Tablets
25 mg each

Geri-dryl Allergy Relief Label (L681 01 Gcp)

Geri-dryl Allergy Relief Label (L681 01 Gcp)

* Please review the disclaimer below.